Cytek Biosciences's total assets for Q1 2026 were $449.11M, a decrease of -2.69% from the previous quarter. CTKB total liabilities were $121.47M for the fiscal quarter, a 1.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.